Ancora Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-702
| Closed | -$41.7K | – | 2417 |
|
|
2025
Q4 | $41.7K | Sell |
702
-216
| -24% | -$11.8K | ﹤0.01% | 1207 |
|
|
2025
Q3 | $49.7K | Hold |
918
| – | – | ﹤0.01% | 1035 |
|
|
2025
Q2 | $50.5K | Sell |
918
-75
| -8% | -$4.42K | ﹤0.01% | 1020 |
|
|
2025
Q1 | $70.2K | Sell |
993
-300
| -23% | -$20.2K | ﹤0.01% | 935 |
|
|
2024
Q4 | $85K | Sell |
1,293
-350
| -21% | -$23.4K | ﹤0.01% | 884 |
|
|
2024
Q3 | $115K | Sell |
1,643
-150
| -8% | -$12.5K | ﹤0.01% | 792 |
|
|
2024
Q2 | $148K | Hold |
1,793
| – | – | ﹤0.01% | 734 |
|
|
2024
Q1 | $157K | Buy |
1,793
+43
| +2% | +$3.85K | ﹤0.01% | 724 |
|
|
2023
Q4 | $169K | Sell |
1,750
-150
| -8% | -$13.3K | ﹤0.01% | 706 |
|
|
2023
Q3 | $168K | Hold |
1,900
| – | – | ﹤0.01% | 694 |
|
|
2023
Q2 | $165K | Hold |
1,900
| – | – | ﹤0.01% | 689 |
|
|
2023
Q1 | $185K | Hold |
1,900
| – | – | 0.01% | 664 |
|
|
2022
Q4 | $197K | Sell |
1,900
-200
| -10% | -$18.8K | 0.01% | 673 |
|
|
2022
Q3 | $178K | Sell |
2,100
-25
| -1% | -$2.23K | 0.01% | 759 |
|
|
2022
Q2 | $176K | Sell |
2,125
-91
| -4% | -$7.25K | 0.01% | 795 |
|
|
2022
Q1 | $171K | Sell |
2,216
-125
| -5% | -$10.5K | ﹤0.01% | 845 |
|
|
2021
Q4 | $207K | Buy |
2,341
+1,916
| +451% | +$158K | ﹤0.01% | 791 |
|
|
2021
Q3 | $33K | Buy |
425
+350
| +467% | +$27.6K | ﹤0.01% | 1317 |
|
|
2021
Q2 | $6K | Hold |
75
| – | – | ﹤0.01% | 1646 |
|
|
2021
Q1 | $6K | Hold |
75
| – | – | ﹤0.01% | 1522 |
|
|
2020
Q4 | $7K | Sell |
75
-200
| -73% | -$15.9K | ﹤0.01% | 1248 |
|
|
2020
Q3 | $21K | Hold |
275
| – | – | ﹤0.01% | 1007 |
|
|
2020
Q2 | $34K | Hold |
275
| – | – | ﹤0.01% | 894 |
|
|
2020
Q1 | $23K | Buy |
+275
| New | +$23.7K | ﹤0.01% | 1026 |
|
Other funds holding BMRN
VCM
VPM
